Labelling and Clinical Performance of Human Leukocytes Labelled with 99mTc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent
Table 1
Summary of clinical results of patients with WBCs prepared using HES-Leukokit® or Gelofusine-Leukokit®.
Accuracy (%)
Sensitivity (%)
Specificity (%)
PPV (%)
NPV (%)
HES
Osteomyelitis ()
87.5
50
100
100
85.7
Hip prosthesis ()
84.6
100
83.3
33.3
100
Vascular grafts ()
100
100
100
100
100
Knee prosthesis ()
95
100
94.4
66.7
100
All ()
90.9 (74.9–96.1)
83.3 (22.3–95.7)
92.1 (78.1–98.3)
62.5 (18.4–90.1)
97.2 (81.3–99.3)
Gelofusine
Osteomyelitis ()
100
100
100
100
100
Hip prosthesis ()
93.8
66.7
100
100
92.9
Vascular grafts ()
100
100
100
100
100
Knee prosthesis ()
100
100
100
100
100
All ()
98.3 (90.8–100)
91.7 (61.5–99.8)
100 (92.3–100)
100 (71.5–100)
97.9 (88.7–99.9)
All values are expressed as percentage, and the confidence intervals are given in brackets.
